...GlaxoSmithKline Ethical Issues 2012 What happened (facts) GlaxoSmithKline (GSK) is one of the leading pharmaceutical companies in the world. They are based in London and they sell their products all over the world. Back in 2012 they were confronted with legal issues and plead guilty on 3 criminal counts. GSK paid a settlement of 3.5 billion dollars to support those charges. Unethical and illegal actions performed by GSK during that period ran from bribing doctors, to misreporting data from a trial and manipulating medical research data. Case Analysis (stakeholders) The stakeholders involved in this case were consumers, upper management, doctors and stockholders. Consumers were negatively affected because they were unconsciously taking ineffective and potentially life threatening medications. Upper management is directly responsible for the illegal actions. Some of the doctors who received bribes from GSK lost their medical license. Stockholders lost money because there was a negative impact on GSK reputation and stock. Model projection Information rights & obligations: On individual level they were unethical in withholding information and furnishing wrong information regarding their products. Society did not know this and this was against the law on political level. Accountability & Control: here it was a case of who should be held liable for unethical behavior affecting all the aforementioned stakeholders. In my opinion the upper management of...
Words: 427 - Pages: 2
...Backup of GlaxoSmithKline Bangladesh Ltd Introduction: Of all the areas of industrial psychology perhaps the most important and certainly the least understood, is that of motivation of workers. It is saying, “A horse can be compelled forcefully to move up to water, but we can’t compel them to work honestly, efficiently, effectively and economically if they are not motivated. Human factor is the most important factor of industrial production and that human factor is the most complicated phenomenon of industrial life. Mishandling of this complicated factor of production may lead to serious consequences. Workforce must be motivated to achieve desired goal. The Pharmaceutical factories of Bangladesh are one of the most important industrial sectors of the country. There are national and multinational pharmaceuticals companies in our country. There are some obvious factors of motivation which can lead the workmen of the pharmaceuticals industries to attain desired goal; higher productivity; of the companies & the absence of such factors lead to labor unrest and fails to secure company’s target, hence the matter should studied and try to locate the reasons for which the dissatisfaction in labor is prevailing and need to find out the possible scheme for motivating workmen for better performance. GlaxoSmithKline Bangladesh Ltd, from its early stage has stimulated the pharmaceutical Industry of the country with its variant existence. The top management team of GlaxoSmithKline Bangladesh...
Words: 11145 - Pages: 45
...GlaxoSmithKline company profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figures for 2003 (in £ million) Sales 21,441 Materials and production costs 4,188 Marketing and administration 7,563 R&D expenditures 2,770 Operating income 6,920 Net profit 4,765 GSK has two main business divisions, pharmaceuticals and consumer healthcare. This profile deals with the pharmaceuticals division, which generates 85% of GSK’s sales. The five largest selling GSK products are Seretide/Advair for asthma and Chronic Obstructive Pulmonary Disease (COPD); Paxil/Seroxat and Wellbutrin, both antidepression drugs; Avandia/Avadamet for type 2 diabetes; and the antibiotic Augmentin. Each of these drugs generated above £800 million of sales in 2003. GSK produces a broad range of products of special importance to developing countries, including: Anti-malaria drugs Zentel (albendazole), for de-worming and the prevention of lymphatic filariasis Pentosam, against leishmaniasis Anti-retrovirals (ARVs) for the treatment of HIV/AIDS Tuberculosis drugs Vaccines for developing countries Corporate...
Words: 18642 - Pages: 75
...Faculty of Business Administration Jatiya Kabi Kazi Nazrul Islam University BBA Program “Human Resource Management” Topic Performance Appraisal Process of GlaxoSmithKline (GSK) Bangladesh Limited. Course coordinator Amita Das Lecturer, Dept.of HRM Date of Submission - 08/07/2012 Submitted by Md.Shamirul Islam 2nd year 1st semester ID: 11133027 Letter of Transmittal July 08, 2012 Amita Das Lecturer, Dept of HRM Jatiya Kabi Kazi Nazrul Islam University Subject: Submission of Assignment on Performance Appraisal Process of GSK Limited Bangladesh. Dear Madam, I feel very glad to inform you that I am going to submit my assignment titled HRM based on Performance Appraisal Process of GSK Limited Bangladesh. I have tried my level best to prepare this assignment & included all those data that is essential for it. Thanking you for your valuable information. Sincerely yours, ............................... Md.Shamirul Islam Executive summary As a part of our curriculum we have to prepare reports in each semester for each subject. In this way, my course teacher has assigned me to prepare the report. And the topic of my report is “Performance Appraisal Process of GlaxoSmithKline (GSK) Bangladesh Limited”. She took a lecture on preparation of this report and serving us necessary documents. As I have selected a pharmaceutical organization...
Words: 4236 - Pages: 17
...------------------------------------------------- Financial STatement analysis GlaxoSmithKline Limited Company June 15, 2015 GROUP: 6 | SL.No | Name | ID | Remarks | 1. | Md. Arif Hossain | 20-066 | | 2. | Abdullah-Al-Noman | 20-128 | | 3. | Md. Abdul Hamid | 20-110 | | 4. | Rasheduzzaman | 20-070 | | 5. | Md. AmanUllah | 20-116 | | 6. | SumiAkterRitu | 20-030 | | | | | Prepared for: | Tanvir Hamim | Lecturer | Department of Banking and Insurance | Faculty of Business Studies | University of Dhaka | | Date of Submission: June 15th, 2015. Table of contents Sl. No. | Particulars | Page | 1. | Introduction 1.1 Background of the study 1.2 Objective of the study 1.3 Scope of the study 1.4 Metholodgy of the study 1.5 Limitation of the study | 6-766677 | 2. | Organizational overview2.1 GSK Bangladesh 2.2 Mission, strategic intent & spirit of GSK Bangladesh2.3 Quality statement | 8-118-91011 | 3. | Analysis of financial statement of GSK Ltd. GlaxoSmithKline Bangladesh Limited | 12-15 | 4. | Ratio analysis of GSK limited company | 16-28 | 5. | Conclusion | 29 | 6. | Reference | 30 | Letter of Transmittal To Tanvir Hamim Lecturer Department of Banking and Insurance University of Dhaka Subject: Submission of Report on “Analysis of Financial Statement GSK”. Dear Sir, We would like to thank you for the guidance and support you have provided us during the course of this report. Without your help, this...
Words: 4743 - Pages: 19
...informs Vol. 36, No. 3, May–June 2006, pp. 191–193 issn 0092-2102 eissn 1526-551X 06 3603 0191 ® doi 10.1287/inte.1060.0214 © 2006 INFORMS Supply Chain Management: Technology, Globalization, and Policy at a Crossroads Tuck School of Business, Dartmouth College, Hanover, New Hampshire 03768, m.eric.johnson@dartmouth.edu M. Eric Johnson Supply chain management is an important application area for INFORMS, with many opportunities for our community to contribute models and insight. The seemingly relentless forces of globalization and technology continually present us with new supply chain challenges and opportunities for further progress. Over the past decade, researchers and practitioners have developed many models and methods that have influenced supply chain practices. However, as managers and management scientists have embraced these new approaches for improving supply chain competitiveness, these initiatives have slipped into the middle of many important corporate and public debates. Key words: supply chain management; professional: comments on. T he forces of globalization and technology are changing supply chains. In many cases, the supply chains are literally disintegrating. Product designers, marketers, and manufacturers that were previously housed in a single facility are now spread over several continents in organizations with different cultures, languages, and business objectives. For example, not long ago, apparel firms, such as Levi Strauss and Company...
Words: 1497 - Pages: 6
...The Pharmaceutical industry in the Global Economy Summer 2005 Larry Davidson* and Gennadiy Greblov Indiana University Kelley School of Business Bloomington, Indiana *Davidson is Professor of Business Economics and Public Policy and Greblov is working towards his MBA degree at the Kelley School of Business Prepared for the Indiana Economic Development Corporation with the support of the Center for International Business Education and Research at the Indiana University Kelley School of Business. Information Services via the World Trade Atlas, U.S. State Export Edition. To receive free copies of the export report please contact the Indiana Economic Development Corporation’s Office of International Trade at 317.232.4949. Direct questions to the authors of the report to Larry Davidson at davidso@indiana.edu or 812.855.2773. Introduction This paper summarizes the results of our global pharmaceutical industry analysis and is intended to increase awareness of the general public – investors, policy makers, managers, employees of the companies – about its current developments. The paper has the following major goals: 1) To analyze the current situation, major challenges and the prospects of the pharmaceutical industry; 2) To identify major players of the global pharmaceutical industry and make a comparative analysis of their business practices and financial results; 3) To determine the relative position of the U.S. pharmaceutical...
Words: 10094 - Pages: 41
...Internship Report On “GSK’S Financial Performance Trend Analysis” Azizur Rahman Submitted By:- 08104091 _ _ _ _ _ _ _ _ _ _ _ _ _ 400 BUS – Spring 2012 . Jabir Al Mursalin Submitted To:- MdLecturer of BRAC Business School BRAC University Dept: BBS Date of Submission: 24th May, 2012 Letter of Endorsement The Internship Report entitled GSK’S Financial Performance Trend Analysis has been submitted for partial fulfillment of the requirements for the degree of Bachelor of Business Administration, Major in Marketing & Finance Faculty of BRAC Business School on Spring 2012 by Mr. Md. Jabir Al Mursalin, Id # 08104091. The report has been accepted and may be presented to the Internship Defense Committee for evaluation. (Any opinions, suggestions made in this report are entirely that of the author of the report. The University does not condone nor reject any of these opinions or suggestions). ______________________ “Mr. Md. Jabir Al Mursalin” Lecturer...
Words: 10391 - Pages: 42
...Finance Faculty of BRAC Business School on Spring 2012 by Mr. Md. Jabir Al Mursalin, Id # 08104091. The report has been accepted and may be presented to the Internship Defense Committee for evaluation. (Any opinions, suggestions made in this report are entirely that of the author of the report. The University does not condone nor reject any of these opinions or suggestions). ______________________ “Mr. Md. Jabir Al Mursalin” Lecturer Academic Internship Supervisor Transmittal Message May 24, 2012 Mr. Md. Jabir Al Mursalin Lecturer BRAC Business School Subject: Letter of Transmittal Dear Sir, I am taking the opportunity to submit the report on “GSK’S Financial Performance Trend Analysis" as a requirement of my internship at GlaxoSmithKline Bangladesh Ltd. under the BBA Program of BRAC University -Bangladesh I worked as an Intern in the Secretarial & Legal Division at GSK Bangladesh Ltd. for 12 weeks gaining a working knowledge of the various finance and administrative procedures and documents that exist in the organization. As a part of the internship requirements, I was obliged to choose a topic for my internship report with approval from my academic supervisor. In this report, I tried to apply the knowledge and guidelines from my education extent to analyze the financial performance of GSK based on which I have tried to forecast...
Words: 10563 - Pages: 43
...Detail-Document #241001 −This Detail-Document accompanies the related article published in− PHARMACIST’S LETTER / PRESCRIBER’S LETTER October 2008 ~ Volume 24 ~ Number 241001 Stability of Refrigerated and Frozen Drugs —Chart modified November 2008— (Based on U.S. product labeling and relevant studies) Failure to follow storage recommendations of pharmaceutical products can result in subpotent products and potentially, therapeutic failure.1-3 In addition, hundreds of thousand of medications are discarded each year because of improper storage conditions resulting in millions of dollars wasted.1,2 This can occur for a variety of reasons including improper shipping, failure to refrigerate or freeze a product upon receipt or after use, and in the event of a power failure. It is important to recognize when pharmaceutical products have not been stored according to the manufacturer’s specifications and take appropriate action. Depending on the product, lot number and expiration date, time of exposure to temperatures outside of the recommended range and actual temperature of exposure, some medications may be deemed suitable for administration while others should be discarded. The following chart provides general guidelines for the room temperature stability of common medications and vaccines which are stored in the refrigerator or freezer. However, if a pharmaceutical product has not been stored according to the recommended conditions, it is important to contact the manufacturer...
Words: 5272 - Pages: 22
...The Pharmaceutical industry in the Global Economy Summer 2005 Larry Davidson* and Gennadiy Greblov Indiana University Kelley School of Business Bloomington, Indiana *Davidson is Professor of Business Economics and Public Policy and Greblov is working towards his MBA degree at the Kelley School of Business Prepared for the Indiana Economic Development Corporation with the support of the Center for International Business Education and Research at the Indiana University Kelley School of Business. Information Services via the World Trade Atlas, U.S. State Export Edition. To receive free copies of the export report please contact the Indiana Economic Development Corporation’s Office of International Trade at 317.232.4949. Direct questions to the authors of the report to Larry Davidson at davidso@indiana.edu or 812.855.2773. Introduction This paper summarizes the results of our global pharmaceutical industry analysis and is intended to increase awareness of the general public – investors, policy makers, managers, employees of the companies – about its current developments. The paper has the following major goals: 1) To analyze the current situation, major challenges and the prospects of the pharmaceutical industry; 2) To identify major players of the global pharmaceutical industry and make a comparative analysis of their business practices and financial results; 3) To determine the relative position of the U.S. pharmaceutical...
Words: 10094 - Pages: 41
...1.EXECUTIVE SUMMARY Executive summary: While studying the HR procedures it was conspicuous that the recruitment and selection procedures are of greater importance for any organization. As GlaxosmithKline Pharmaceuticals Ltd. is an esteemed organization in Nashik the response to recruitment advertisement was huge. During my training period I was a part of recruitment and selection procedure. My primary task was to screen the resumes of the applicants and thus to select the candidates for the interview sessions. The selection procedures included written tests and interviews. After every stage the selected candidates are moved to the next level while the rejected candidates are again called for the feedback. The objective with which the study was conducted are as follows, To understand: 1. The functioning of Recruitment and Selection. 2. To have exposure to recruitment process 3. Whether the recruitment process and selection process are satisfactory or not. The major findings about the recruitment and selection procedures are as follows, * The overall satisfaction level is high. * Job profile communication, evaluation of experience is the factors where Glaxosmithkline is scoring well. * The recruitment is mainly done through print media. * The selection procedures are having three phases. * The executives want the procedure to be future oriented. Following were the suggestions given for the improvement in the procedures. ...
Words: 14022 - Pages: 57
...Research and Analysis Project for B.sc (Hons) In Applied Accounting Business and Financial Performance Of GlaxoSmithKline Pakistan Ltd (2007- 2009) XXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXX Prepared by Faisal Saleem XXXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXXX Mentoring by Fahim Ahmed This project is prepared in accordance with Oxford Brookes University guidelines. Table of Contents Topic & Company selection------------------------------------------------------------------------------3 About GlaxoSmithKline------------------------------------------------------------------------------------4 Overview of the Pharmaceutical Industry-------------------------------------------------------------5 Research Aims and Objectives--------------------------------------------------------------------------7 Information Gathering--------------------------------------------------------------------------------------8 Techniques used in RAP--------------------------------------------------------------------------------10 Limitations in RAP and Ethical issues----------------------------------------------------------------11 Financial Analysis-----------------------------------------------------------------------------------------12 Revenue trend Analysis----------------------------------------------------------------------------------12 Profitability and...
Words: 12319 - Pages: 50
...Why is malaria such a problem and how close are we to an effective vaccine for this deadly disease? The problem. It was well over 100 years ago that scientists discovered the cause of malaria as a single-cell parasite called plasmodium but, even today, this life-threatening parasitic disease represents one of the international community’s most pressing public health problems. Malaria is endemic throughout the tropical regions of the world, causing more than 300 million acute illnesses and at least one million deaths each year1 . Children under the age of 5 are particularly prone to infection, and, as a direct result of their immature immunity to disease, make up a dramatic proportion of the deaths each year. In Africa alone (where 90% of all malariaattributed deaths occur) this disease is responsible for the death of one child in 20 before the age of 52. In fact, malaria is the world’s leading cause of childhood mortality, killing one child every 30 seconds3 . Pregnant women and their unborn children are also particularly vulnerable to the disease which contributes to anaemia, premature birth and low birth weight whilst foreign travellers, who have often not developed immunity, represent another high-risk group.4 Malaria is caused by a protozoan parasite, Plasmodium. Four species of Plasmodium can cause the disease in humans: P. vivax, P. ovale, P. malarinae and P.falciparum, which is by far the most deadly. The disease is vector-borne and is transmitted...
Words: 4639 - Pages: 19
............................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ................................................................................................................................................. 6 Indian Pharma Industry................................................................................................................................. 7 Drivers of the Demand ............................................................................................................................
Words: 7934 - Pages: 32
